Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China flag China · Delayed Price · Currency is CNY
2.630
-0.090 (-3.31%)
Nov 17, 2026, 3:00 PM CST

SHA:603363 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
487.47697.571,384207.66719.08542.98
Trading Asset Securities
51.111.814.62.611
Cash & Short-Term Investments
492.47698.681,386212.26721.69543.98
Cash Growth
-29.46%-49.58%552.83%-70.59%32.67%-4.95%
Accounts Receivable
770.88510.21393.11650.92515.16526.79
Other Receivables
864.93840.06739.1246.9258.02266.97
Receivables
1,6361,3501,132897.82773.18793.76
Inventory
1,199955.4816.941,3283,2892,589
Prepaid Expenses
-0.0500.080.030.04
Other Current Assets
297.52327.53364.34350.82331.74336.59
Total Current Assets
3,6253,3323,6992,7895,1154,263
Property, Plant & Equipment
3,9624,1144,4248,69111,07810,702
Long-Term Investments
133.32132.93167.76331.59306.41175.35
Goodwill
337.22337.74345.39386.31439.17488.51
Other Intangible Assets
308.34315.96328.81424.38651.2462.7
Long-Term Deferred Tax Assets
136.05142.63142.07166.89253.22150.77
Long-Term Deferred Charges
163167.82159.57335.89354.11320.94
Other Long-Term Assets
170.51199.15239.13499.99466.2536.96
Total Assets
8,8358,7429,50613,62518,66317,101

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,7501,4101,6753,5574,1183,912
Accrued Expenses
77.64191.83255.59230.08404.46330.34
Short-Term Debt
300.52297.74765.333,8353,9753,654
Current Portion of Long-Term Debt
668.44506.98410.581,2091,079380.77
Current Portion of Leases
-72.5994.54662.62813.06702.36
Current Income Taxes Payable
21.5610.8715.0227.6316.38
Current Unearned Revenue
124.6138.28172.39327.88252.9262.13
Other Current Liabilities
1,287937.51,2341,523975.74858.49
Total Current Liabilities
4,2293,5664,61411,35911,64510,117
Long-Term Debt
1,1961,2791,4621,1821,5792,916
Long-Term Leases
190.49172.83182.81,3701,8281,709
Long-Term Unearned Revenue
91.9199.64108.73173.05149.2109.36
Long-Term Deferred Tax Liabilities
11.3312.1813.7318.8823.6725.52
Other Long-Term Liabilities
33.6131.7963.3625.163.9430.56
Total Liabilities
5,7525,1626,44514,12815,22914,908

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,7312,6032,606870.27871.06684.41
Additional Paid-In Capital
5,6415,4755,0043,7763,6641,535
Retained Earnings
-5,290-4,899-4,976-5,556-1,905-867.43
Treasury Stock
-269.01--17.56-17.46-81.9-158.81
Comprehensive Income & Other
-49.54-48.94-49.85-36.54-42.86110.07
Total Common Equity
2,7633,1302,566-962.972,5061,303
Minority Interest
320.29449.73494.97459.75929.26889.52
Shareholders' Equity
3,0833,5803,061-503.223,4352,193
Total Liabilities & Equity
8,8358,7429,50613,62518,66317,101

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,3552,3292,9158,2599,2739,362
Net Cash (Debt)
-1,863-1,631-1,530-8,047-8,552-8,818
Net Cash Growth
------
Net Cash Per Share
-0.71-0.63-1.77-9.28-11.04-13.58
Filing Date Shares Outstanding
2,4122,6032,606870.27871.06684.41
Total Common Shares Outstanding
2,4122,6032,606870.27871.06684.41
Working Capital
-604.25-234.01-914.89-8,570-6,530-5,854
Book Value Per Share
1.151.200.98-1.112.881.69
Tangible Book Value
2,1172,4771,892-1,7741,415352.26
Tangible Book Value Per Share
0.880.950.73-2.041.620.30
Buildings
-3,0173,1024,8254,8274,170
Machinery
-2,0122,0943,1623,1312,686
Construction In Progress
-421.8474.14954.261,1751,288